Keyphrases
Systemic Lupus Erythematosus
100%
Clinical Characteristics
100%
Autoantibodies
100%
Medication Use
100%
Clinical Medication
100%
European American
85%
African American
57%
Hispanic
42%
Antinuclear Antibodies
28%
Hydroxychloroquine
28%
Rheumatic Diseases
28%
Hispanic Patients
28%
Precipitins
28%
Latin America (LATAM)
14%
Sjgren's Syndrome
14%
Lupus
14%
Clinical Presentation
14%
Medical Records
14%
American College of Rheumatology
14%
Therapeutic Intervention
14%
Methotrexate
14%
Classification Criteria
14%
Indirect Immunofluorescence
14%
Racial-ethnic Groups
14%
Systemic Autoimmune Diseases
14%
Raynaud's Phenomenon
14%
Young Age
14%
Titre
14%
Autoantibody Profile
14%
Anticardiolipin
14%
Systemic Sclerosis
14%
Mycophenolate Mofetil
14%
Interstitial Lung Disease
14%
Autoantibody Specificity
14%
Anti-double Stranded DNA
14%
Disease Symptoms
14%
IgG ELISA
14%
Family Registry
14%
Medicine and Dentistry
Systemic Lupus Erythematosus
100%
Autoantibody
100%
Hydroxychloroquine
28%
Rheumatic Disease
28%
Antinuclear Antibody
28%
Precipitin
28%
Lupus Erythematosus
14%
Medical Record
14%
Systemic Autoimmune Disease
14%
Immunoglobulin M
14%
Methotrexate
14%
Rheumatology
14%
Enzyme Linked Immunosorbent Assay
14%
Ethnic Group
14%
Azathioprine
14%
Immunofluorescence
14%
Mycophenolate Mofetil
14%
Raynaud Phenomenon
14%
Interstitial Lung Disease
14%
Systemic Scleroderma
14%
Immunology and Microbiology
Systemic Lupus Erythematosus
100%
Autoantibody
100%
Hydroxychloroquine
28%
Antinuclear Antibody
28%
Rheumatic Disease
28%
Precipitin
28%
Medical Record
14%
Immunoglobulin M
14%
ELISA
14%
Immunofluorescence
14%
Methotrexate
14%
Systemic Autoimmune Disease
14%
Raynaud Phenomenon
14%
Lupus Erythematosus
14%
Systemic Scleroderma
14%
Azathioprine
14%
Mycophenolate Mofetil
14%